Genus’ (GNS) “Buy” Rating Reiterated at Liberum Capital

Liberum Capital reiterated their buy rating on shares of Genus (LON:GNS) in a report released on Monday, ThisIsMoney.Co.Uk reports.

Separately, Peel Hunt restated a buy rating on shares of Genus in a report on Thursday, March 5th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company currently has a consensus rating of Buy and an average target price of GBX 3,177.83 ($41.80).

Shares of Genus stock opened at GBX 3,420 ($44.99) on Monday. The business has a 50-day moving average price of GBX 3,173.28 and a 200 day moving average price of GBX 3,072.21. The firm has a market cap of $2.23 billion and a P/E ratio of 59.38. The company has a quick ratio of 1.12, a current ratio of 1.81 and a debt-to-equity ratio of 27.93. Genus has a fifty-two week low of GBX 2,158 ($28.39) and a fifty-two week high of GBX 3,709.98 ($48.80).

The business also recently disclosed a dividend, which will be paid on Thursday, April 2nd. Investors of record on Thursday, March 5th will be issued a dividend of GBX 9.40 ($0.12) per share. The ex-dividend date of this dividend is Thursday, March 5th. This represents a yield of 0.3%. Genus’s dividend payout ratio (DPR) is presently 0.49%.

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.

Read More: Range Trading

Analyst Recommendations for Genus (LON:GNS)

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.